PATENT CLAIM ANALYSIS

Application Number: 15764918
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "133100"]

Abstract:
The present invention provides antagonists of IL-17C for use in the treatment and/or prevention of atopic dermatitis and related conditions.

Claim (Index 18):
The method of  claim 13  wherein said antibody or antibody fragment cross-competes with an antibody comprising a HCDR1 comprising the amino acid sequence of SEQ ID No.: 4, a HCDR2 comprising the amino acid sequence of SEQ ID No.: 5, a HCDR3 comprising the amino acid sequence of SEQ ID No.: 6, a LCDR1 comprising the amino acid sequence of SEQ ID No.: 7, a LCDR2 comprising the amino acid sequence of SEQ ID No.: 8 and a LCDR3 comprising the amino acid sequence of SEQ ID No.: 9 or cross-competes with an antibody comprising a HCDR1 comprising the amino acid sequence of SEQ ID No.: 14, a HCDR2 comprising the amino acid sequence of SEQ ID No.: 15, a HCDR3 comprising the amino acid sequence of SEQ ID No.: 16, a LCDR1 comprising the amino acid sequence of SEQ ID No.: 17, a LCDR2 comprising the amino acid sequence of SEQ ID No.: 18 and a LCDR3 comprising the amino acid sequence of SEQ ID No.: 19.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.05
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15711815', '14632988', '14328336', '15436032', '15563743']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7097782557459787
- 35 USC 102 Novelty (BERT): 0.5194097859617487
- Combined Prediction Score: 0.6907414087675557
- Mean Citation Score: 293.713394
- Max Citation Score: 319.89307
- Similarity Product: 227.6856565092397

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test